Lv21
160 积分 2024-06-18 加入
国家卫生健康委员会中国结直肠癌诊疗规范（2025）
1天前
已关闭
Zanidatamab: First Approval
2个月前
已完结
HER2-Targeted Therapies: Unraveling Their Role in Biliary Tract Cancers
2个月前
已完结
Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape
1年前
已完结
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
1年前
已完结
皖公网安备34019202002308
